lactoferrin and Agranulocytosis

lactoferrin has been researched along with Agranulocytosis* in 6 studies

Other Studies

6 other study(ies) available for lactoferrin and Agranulocytosis

ArticleYear
Antibacterial prophylaxis with lactoferrin in neutropenic patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:4

    The prevention of enterogenic infection by human lactoferrin was tested in five neutropenic patients receiving chemotherapy for acute myelogenous leukemia. Lactoferrin did not significantly delay the onset of infection but reduced its duration and severity as judged from the course of fever. Compared with nine matched controls, lactoferrin-treated patients had a lower incidence of bacteremia on the whole and of gram-negative bacteremia in particular.

    Topics: Adolescent; Adult; Agranulocytosis; Female; Fever; Humans; Lactoferrin; Lactoglobulins; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Sepsis

1989
Serum levels of lactoferrin and myeloperoxidase in chronic idiopathic and secondary neutropenia. A preliminary report.
    Scandinavian journal of haematology, 1986, Volume: 36, Issue:4

    In 20 patients with chronic neutropenia, serum lactoferrin (S-LF) and serum myeloperoxidase (S-MPO) levels were assessed. By immunofluorescence, granulocyte-bound immunoglobulins were detected in 12 patients, whereas circulating immune complexes were found in the blood of 8 patients by the 125-I-C1q-binding test (C1q-BT). In both groups of patients, there was a relative increase of S-LF and a relative or sometimes absolute increase of S-MPO. In the latter group, results of the C1q-BT correlated positively with S-MPO but negatively with neutrophil counts. No correlations between S-LF or S-MPO and the results of the granulocyte immunofluorescence test were found. Our results suggest that S-LF and S-MPO levels may be helpful in the further study of patients with chronic neutropenia, to gain more insight into the pathogenetic mechanisms operative in this disease.

    Topics: Agranulocytosis; Chronic Disease; Complement Activating Enzymes; Complement C1q; Fluorescent Antibody Technique; Granulocytes; Humans; Lactoferrin; Lactoglobulins; Leukocyte Count; Neutropenia; Peroxidase

1986
Relationship of plasma lactoferrin content to neutrophil regeneration and bone marrow infusion.
    Scandinavian journal of haematology, 1986, Volume: 36, Issue:1

    Plasma concentrations of lactoferrin were measured in immediately separated EDTA samples from 5 subjects who had received HLA identical bone marrow transplants for leukaemia or aplastic anaemia and from 7 subjects who were leukopenic as a consequence of chemotherapy for a variety of malignant conditions. Plasma lactoferrin concentrations were found to closely parallel the leucocyte count and were not found to either predict or to antedate leucocyte regeneration. Serial measurements of plasma lactoferrin in a subject with no circulating neutrophils who received a bone marrow graft revealed that the clearance of lactoferrin followed an exponential pattern and had an initial half time of 2.2 h.

    Topics: Agranulocytosis; Anemia, Aplastic; Bone Marrow Transplantation; Hematopoiesis; Humans; Kinetics; Lactoferrin; Lactoglobulins; Leukemia; Leukocyte Count; Neoplasms; Neutropenia; Neutrophils

1986
Plasma lactoferrin in patients with neutropenia.
    Blut, 1986, Volume: 52, Issue:5

    This study examines the role of plasma lactoferrin in the assessment of neutropenia. In particular, we have studied lactoferrin as an inhibitor of granulopoiesis and as an indicator of the size of the total blood granulocyte pool (TBGP). Plasma lactoferrin concentration was determined in a heterogeneous group of 30 patients with neutropenia. Serial plasma lactoferrin levels in a patient with cyclic neutropenia correlated with the cycles of the neutrophil count. Patients with splenomegaly had a grossly elevated lactoferrin:neutrophil ratio. Most chronic idiopathic neutropenia patients had no real clinical problems and a normal plasma lactoferrin level. The results provide further evidence to support the concept that plasma lactoferrin indicates the size of the TBGP and the lactoferrin: neutrophil ratio indicates the degree of granulocyte margination. There was no evidence to suggest that lactoferrin acting as a feedback inhibitor of granulopoiesis caused neutropenia in these patients.

    Topics: Agranulocytosis; Anemia, Aplastic; Bone Marrow Cells; Colony-Forming Units Assay; Felty Syndrome; Humans; Lactoferrin; Lactoglobulins; Methods; Neutropenia; Radioimmunoassay

1986
Neutropenia induced by systemic infusion of lactoferrin.
    The Journal of laboratory and clinical medicine, 1982, Volume: 99, Issue:6

    Rabbit granulocyte lactoferrin, when infused into hamsters or rabbits, induces transient neutropenia, and in hamsters the lactoferrin promotes adherence of the granulocytes to the endothelial cell wall as monitored visually. In contrast, neither rabbit granule lysozyme nor human transferrin induces neutropenia in the rabbit nor does transferrin or bovine serum albumin affect the adherent properties in vivo of the phagocytic cells of the hamster. Thus lactoferrin enhances granulocyte adherence both in vivo and in vitro. It would appear that the promotion of margination of leukocytes by lactoferrin in vivo may contribute to the phenomenon of neutropenia during activation of granulocytes by chemotactic factors.

    Topics: Agranulocytosis; Albumins; Animals; Cell Adhesion; Cell Aggregation; Chemotactic Factors; Cricetinae; Endothelium; Granulocytes; Infusions, Parenteral; Lactoferrin; Lactoglobulins; Leukocyte Count; Muramidase; Neutropenia; Rabbits; Transferrin

1982
Serum myeloperoxidase and lactoferrin in neutropenia.
    Scandinavian journal of haematology, 1977, Volume: 18, Issue:1

    Radioimmunosorbent assays for determination of serum content of the neutrophil proteins myeloperoxidase and lactoferrin are described. Serial studies were performed in patients with neutropenia. In 2 cases of cyclic neutropenia the myeloperoxidase level showed slight variations within the normal range during the cycle while lactoferrin displayed a clear correlation with neutrophil counts. In 1 case with persistent agranulocytosis myeloperoxidase was normal but lactoferrin was extremely low. During the regeneration phase of drug-induced neutropenia neutrophil counts and serum lactoferrin increased in a parallel fashion. Since serum myeloperoxidase was normal during profounded neutropenia it is suggested to derive primarily from myeloperoxidase-rich granulopoietic precursor cells of the marrow. Serum lactoferrin on the other hand seems to derive from leakage of more granulopoietic cells of blood and marrow. Studies of neutrophil proteins of serum may aid in evaluation of neutropenic patients.

    Topics: Adolescent; Adult; Agranulocytosis; Female; Humans; Lactoferrin; Lactoglobulins; Leukocyte Count; Male; Neutropenia; Periodicity; Peroxidase; Peroxidases; Radioimmunosorbent Test

1977